SMTL ID : 1sv5.1

CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 65B: 4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE(Non-covalent)

65B.1: 14 residues within 4Å: Chain A: L.100, K.101, K.102, N.103, V.106, V.179, Y.181, Y.188, P.225, F.227, W.229, L.234, H.235, Y.318 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.100, A:V.106, A:V.106, A:Y.181, A:Y.181, A:Y.188, A:Y.188, A:F.227, A:L.234, A:Y.318 Hydrogen bonds: A:K.101, A:N.103

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Das, K. et al., Roles of Conformational and Positional Adaptability in Structure-Based Design of TMC125-R165335 (Etravirine) and Related Non-nucleoside Reverse Transcriptase Inhibitors That Are Highly Potent and Effective against Wild-Type and Drug-Resistant HIV-1 Variants. J.Med.Chem. (2004)

Release Date

2004-05-11

Peptides

Reverse Transcriptase: A
Reverse Transcriptase: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Reverse Transcriptase

Reverse Transcriptase

Related Entries With Identical Sequence